Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Peritoneal Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00101257
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Fred Hutchinson Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT00574951
What this trial is testing

AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 23
Testing effectiveness (Phase 2)Study completedNCT05041257
What this trial is testing

Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
AbbVie 79
Early research (Phase 1)Study completedNCT01145430
What this trial is testing

Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMale Breast Carcinoma+7 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00420381
What this trial is testing

Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerNeoplasmsCarcinoma
Eli Lilly and Company 28
Large-scale testing (Phase 3)Study completedNCT02311907
What this trial is testing

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityNeuropathyNeurotoxicity Syndrome+13 more
Alliance for Clinical Trials in Oncology 195
Not applicableWithdrawnNCT04276909
What this trial is testing

Feasibility Study of LUM Imaging System for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Lumicell, Inc.
Not applicableUnknownNCT01074398
What this trial is testing

Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Gynecologic Oncology Group 513
Not applicableLooking for participantsNCT06753136
What this trial is testing

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Who this might be right for
Primary Visceral Tumors of Any HistotypeVisceral LesionsLiver Cancer+9 more
Istituto Oncologico Veneto IRCCS 24
Early research (Phase 1)Study completedNCT02898207
What this trial is testing

Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer

Who this might be right for
Metastatic High Grade Fallopian Tube Serous AdenocarcinomaMetastatic Malignant Solid NeoplasmMetastatic Primary Peritoneal Serous Adenocarcinoma+16 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Ended earlyNCT01535157
What this trial is testing

Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerCancer of OvaryCancer of the Ovary+2 more
South Plains Oncology Consortium 12
Early research (Phase 1)Study completedNCT00348699
What this trial is testing

AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Male Breast CancerRecurrent Breast CancerRecurrent Ovarian Epithelial Cancer+7 more
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Study completedNCT00429793
What this trial is testing

Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)UnknownNCT02681432
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
PEDRO VILLAREJO CAMPOS 60
Early research (Phase 1)Study completedNCT02210663
What this trial is testing

Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 16
Testing effectiveness (Phase 2)Study completedNCT01402271
What this trial is testing

Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
European Organisation for Research and Treatment of Cancer - EORTC 88
Very early researchStudy completedNCT02316834
What this trial is testing

Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Serous AdenocarcinomaHigh Grade Ovarian Serous AdenocarcinomaOvarian Mass+16 more
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00183794
What this trial is testing

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

Who this might be right for
Ovarian CarcinomaPeritoneal Neoplasms
University of Southern California 20
Early research (Phase 1)Ended earlyNCT03924245
What this trial is testing

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

Who this might be right for
Fallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more
Vanderbilt-Ingram Cancer Center 3
Early research (Phase 1)Active Not RecruitingNCT02208375
What this trial is testing

MTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian

Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierEndometrial Adenocarcinoma+13 more
M.D. Anderson Cancer Center 159
Next Page